Milestone Pharmaceuticals Inc. (MIST)
NASDAQ: MIST · Real-Time Price · USD
1.100
+0.030 (2.80%)
At close: Aug 14, 2026, 4:00 PM EDT
1.110
+0.010 (0.91%)
After-hours: Aug 14, 2026, 7:45 PM EDT
Milestone Pharmaceuticals Employees
Milestone Pharmaceuticals had 38 employees as of December 31, 2025. The number of employees increased by 5 or 15.15% compared to the previous year.
Employees
38
Change (1Y)
5
Growth (1Y)
15.15%
Revenue / Employee
$61,658
Profits / Employee
-$2,210,816
Market Cap
149.66M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 38 | 5 | 15.15% |
| Dec 31, 2024 | 33 | -14 | -29.79% |
| Dec 31, 2023 | 47 | 8 | 20.51% |
| Dec 31, 2022 | 39 | 10 | 34.48% |
| Dec 31, 2021 | 29 | 1 | 3.57% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Humacyte | 184 |
| LENZ Therapeutics | 152 |
| Molecular Partners AG | 134 |
| Cibus | 118 |
| Aardvark Therapeutics | 28 |
| TuHURA Biosciences | 22 |
| Spruce Biosciences | 22 |
| Unicycive Therapeutics | 22 |
MIST News
- 3 days ago - Milestone Pharmaceuticals Earnings Call Transcript: Q2 2026 - Transcripts
- 3 days ago - Milestone Pharmaceuticals Quarterly report: Q2 2026 - Filings
- 3 days ago - Milestone Pharmaceuticals Earnings release: Q2 2026 - Filings
- 3 days ago - Milestone Pharmaceuticals Registration statement: Q2 2026 - Filings
- 3 days ago - Milestone Pharmaceuticals Slides: Corporate presentation - Filings
- 3 days ago - Milestone Pharmaceuticals Announces Second Quarter 2026 Financial Results and Provides Corporate Update - GlobeNewsWire
- 10 days ago - Milestone Pharmaceuticals to Announce Second Quarter 2026 Financial Results on August 12, 2026 - GlobeNewsWire
- 6 weeks ago - Milestone Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire